Ignite Creation Date:
2025-12-25 @ 1:27 AM
Ignite Modification Date:
2025-12-28 @ 12:12 AM
Study NCT ID:
NCT01127893
Status:
TERMINATED
Last Update Posted:
2021-03-10
First Post:
2010-05-20
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Safety Extension Study Of Tanezumab When Administered By Subcutaneous Injection To Patients With Osteoarthritis
Sponsor:
Pfizer
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2010-06-15
Start Date Type:
ACTUAL
Primary Completion Date:
2010-09-29
Primary Completion Date Type:
ACTUAL
Completion Date:
2010-09-29
Completion Date Type:
ACTUAL
First Submit Date:
2010-05-20
First Submit QC Date:
None
Study First Post Date:
2010-05-21
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2021-01-13
Results First Submit QC Date:
None
Results First Post Date:
2021-03-10
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2012-10-11
Disp First Post Date Type:
ESTIMATED
Last Update Submit Date:
2021-03-03
Last Update Post Date:
2021-03-10
Last Update Post Date Type:
ACTUAL